Category: Cancer Treatment
Cancer Treatment market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Liposomal Doxorubicin
The 2025-2030 World Outlook for Liposomal Doxorubicin This study covers the world outlook for liposomal doxorubicin across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Chronic Lymphocytic Leukemia
The 2025-2030 World Outlook for Chronic Lymphocytic Leukemia This study covers the world outlook for chronic lymphocytic leukemia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Lung Cancer Screening Software
The 2025-2030 World Outlook for Lung Cancer Screening Software This study covers the world outlook for lung cancer screening software across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Hormone Therapy for Prostate Cancer Therapeutics
The 2025-2030 World Outlook for Hormone Therapy for Prostate Cancer Therapeutics This study covers the world outlook for hormone therapy for prostate cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ... Read More
-
The 2025-2030 World Outlook for NDDS in Cancer Therapies
The 2025-2030 World Outlook for NDDS in Cancer Therapies This study covers the world outlook for NDDS in cancer therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Antiemetic Chemotherapy Drugs
The 2025-2030 World Outlook for Antiemetic Chemotherapy Drugs This study covers the world outlook for antiemetic chemotherapy drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Metastatic Bone Diseases
The 2025-2030 World Outlook for Metastatic Bone Diseases This study covers the world outlook for metastatic bone diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Prostate Cancer Therapeutics
The 2025-2030 World Outlook for Prostate Cancer Therapeutics This study covers the world outlook for prostate cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Prostate Cancer Treatments
The 2025-2030 World Outlook for Prostate Cancer Treatments This study covers the world outlook for prostate cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Colorectal Cancer Drugs
The 2025-2030 World Outlook for Colorectal Cancer Drugs This study covers the world outlook for colorectal cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Orphan Cancer Drugs
The 2025-2030 World Outlook for Orphan Cancer Drugs This study covers the world outlook for orphan cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Circulating Tumor Cells
The 2025-2030 World Outlook for Circulating Tumor Cells This study covers the world outlook for circulating tumor cells across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for NDDS for Cancer Therapies
The 2025-2030 World Outlook for NDDS for Cancer Therapies This study covers the world outlook for NDDS for cancer therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Neuroendocrine Tumors
The 2025-2030 World Outlook for Neuroendocrine Tumors This study covers the world outlook for neuroendocrine tumors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for T-Cell Immunotherapies
The 2025-2030 World Outlook for T-Cell Immunotherapies This study covers the world outlook for t-cell immunotherapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Novel Drug Delivery Systems in Cancer Therapies
The 2025-2030 World Outlook for Novel Drug Delivery Systems in Cancer Therapies This study covers the world outlook for novel drug delivery systems in cancer therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More
-
The 2025-2030 World Outlook for Alpha Emitters for Melanoma
The 2025-2030 World Outlook for Alpha Emitters for Melanoma This study covers the world outlook for alpha emitters for melanoma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Biological Cancer Treatments
The 2025-2030 World Outlook for Biological Cancer Treatments This study covers the world outlook for biological cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Melanoma Therapeutics
The 2025-2030 World Outlook for Melanoma Therapeutics This study covers the world outlook for melanoma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Disease-Specific Chronic Myelogenous Leukemia Treatments
The 2025-2030 World Outlook for Disease-Specific Chronic Myelogenous Leukemia Treatments This study covers the world outlook for disease-specific chronic myelogenous leukemia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential in ... Read More
-
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics This study covers the world outlook for non-small cell lung cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
-
The 2025-2030 World Outlook for Liver Cancer Diagnostics
The 2025-2030 World Outlook for Liver Cancer Diagnostics This study covers the world outlook for liver cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Melanoma Scanners
The 2025-2030 World Outlook for Melanoma Scanners This study covers the world outlook for melanoma scanners across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Thyroid Cancer Drugs
The 2025-2030 World Outlook for Thyroid Cancer Drugs This study covers the world outlook for thyroid cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Multiple Myeloma Therapeutics
The 2025-2030 World Outlook for Multiple Myeloma Therapeutics This study covers the world outlook for multiple myeloma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
Research Assistance
